28 research outputs found
Perioperative management of patient with Bombay blood group undergoing mitral valve replacement
Bombay red blood cell phenotype is an extremely rare blood type for which patients can receive only autologous or Bombay phenotype red blood cells. We report a case of stenotic mitral valve with Bombay phenotype who underwent minimal invasive right lateral thoracotomy for the replacement of the mitral valve. A male patient from Bangladesh presented to the hospital with New York Heart Association III symptoms. His medical evaluation revealed severe mitral valve stenosis and mild aortic valve regurgitation. The patient received erythropoietin, intravenous iron succinate and folic acid tablets. Autologous blood transfusion was carried out. The mitral valve was replaced with a prosthetic valve successfully. After weaning off from cardiopulmonary bypass, heparinisation was corrected with protamine. Post-operatively, the patient received autologous red blood cells. The patient recovered after 1-day of inotropic support with adrenaline and milrinone, and diuretics and was discharged on the 5 th post-operative day
Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study
<b>Background: </b> Gabapentin is an antiepileptic drug. Its antiemetic effect is demonstrated in chemotherapy-induced acute and delayed onset of nausea and vomiting in breast cancer patients. <b> Aim:</b> To evaluate the antiemetic effect of gabapentin on incidence and severity of postoperative nausea and vomiting in laparoscopic cholecystectomy. <b> Settings and Design:</b> Double-blind, randomized, placebo-controlled study. <b> Materials and Methods:</b> Two hundred and fifty patients of ASA physical status I and II, scheduled for laparoscopic cholecystectomy were randomly assigned into two equal groups to receive 600 mg gabapentin or matching placebo two hours before surgery. Standard anaesthesia technique was used. Fentanyl was used as rescue postoperative analgesic. Ondansetron 4 mg was used intravenously as rescue medication for emesis. The total number of patients who had nausea or vomiting, and its severity and total fentanyl consumption in the first 24 hours were recorded. <b> Statistical Analysis:</b> "Z test" was used to test the significance of severity of post-operative nausea and vomiting between groups. Fentanyl consumed in each group (Mean±SD) within 24 hrs was compared using student t test. <i> P</i> value< 0.05 was considered significant. <b> Results:</b> There were no demographic difference between the two groups. Incidence of post-operative nausea and vomiting within 24 hrs after laparoscopic cholecystectomy was significantly lower in gabapentin group (46/125) than in the placebo group (75/125) (37.8% <i> vs</i> 60%; <i> P</i> =0.04). There was a significantly decreased fentanyl consumption in gabapentin group (221.2±92.4 µg) as compared to placebo group (505.9±82.0 µg; <i> P</i> =0.01). <b> Conclusion:</b> Gabapentin effectively suppresses nausea and vomiting in laparoscopic cholecystectomy and post-operative rescue analgesic requirement
Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study
Background: Gabapentin is an antiepileptic drug. Its antiemetic effect
is demonstrated in chemotherapy-induced acute and delayed onset of
nausea and vomiting in breast cancer patients. Aim: To evaluate the
antiemetic effect of gabapentin on incidence and severity of
postoperative nausea and vomiting in laparoscopic cholecystectomy.
Settings and Design: Double-blind, randomized, placebo-controlled
study. Materials and Methods: Two hundred and fifty patients of ASA
physical status I and II, scheduled for laparoscopic cholecystectomy
were randomly assigned into two equal groups to receive 600 mg
gabapentin or matching placebo two hours before surgery. Standard
anaesthesia technique was used. Fentanyl was used as rescue
postoperative analgesic. Ondansetron 4 mg was used intravenously as
rescue medication for emesis. The total number of patients who had
nausea or vomiting, and its severity and total fentanyl consumption in
the first 24 hours were recorded. Statistical Analysis: "Z test" was
used to test the significance of severity of post-operative nausea and
vomiting between groups. Fentanyl consumed in each group (Mean\ub1SD)
within 24 hrs was compared using student t test. P value< 0.05 was
considered significant. Results: There were no demographic difference
between the two groups. Incidence of post-operative nausea and vomiting
within 24 hrs after laparoscopic cholecystectomy was significantly
lower in gabapentin group (46/125) than in the placebo group (75/125)
(37.8% vs 60%; P =0.04). There was a significantly decreased fentanyl
consumption in gabapentin group (221.2\ub192.4 \ub5g) as compared
to placebo group (505.9\ub182.0 \ub5g; P =0.01). Conclusion:
Gabapentin effectively suppresses nausea and vomiting in laparoscopic
cholecystectomy and post-operative rescue analgesic requirement
Dexmedetomidine as an adjunct in postoperative analgesia following cardiac surgery: A randomized, double-blind study
Objectives: The purpose of this study was to determine analgesic efficacy of dexmedetomidine used as a continuous infusion without loading dose in postcardiac surgery patients. Settings and Design: A prospective, randomized, double-blind clinical study in a single tertiary care hospital on patients posted for elective cardiac surgery under cardiopulmonary bypass. Interventions: Sixty-four patients who underwent elective cardiac surgery under general anesthesia were shifted to intensive care unit (ICU) and randomly divided into two groups. Group A (n = 32) received a 12 h infusion of normal saline and group B (n = 32) received a 12 h infusion of dexmedetomidine 0.4 μg/kg/h. Postoperative pain was managed with bolus intravenous fentanyl. Total fentanyl consumption, hemodynamic monitoring, Visual Analogue Scale (VAS) pain ratings, Ramsay Sedation Scale were charted every 6 th hourly for 24 h postoperatively and followed-up till recovery from ICU. Student′s t-test, Chi-square/Fisher′s exact test has been used to find the significance of study parameters between the groups. Results: Dexmedetomidine treated patients had significantly less VAS score at each level (P < 0.001). Total fentanyl consumption in dexmedetomidine group was 128.13 ± 35.78 μg versus 201.56 ± 36.99 μg in saline group (P < 0.001). A statistically significant but clinically unimportant sedation was noted at 6 and 12 h (P < 0.001, and P = 0.046 respectively). Incidence of delirium was less in dexmedetomidine group (P = 0.086+). Hemodynamic parameters were statistically insignificant. Conclusions: Dexmedetomidine infusion even without loading dose provides safe, effective adjunct analgesia, reduces narcotic consumption, and showed a reduced trend of delirium incidence without undesirable hemodynamic effects in the cardiac surgery patients
Prophylactic gabapentin for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized, double-blind, placebo-controlled study
Background: Gabapentin is an antiepileptic drug. Its antiemetic effect
is demonstrated in chemotherapy-induced acute and delayed onset of
nausea and vomiting in breast cancer patients. Aim: To evaluate the
antiemetic effect of gabapentin on incidence and severity of
postoperative nausea and vomiting in laparoscopic cholecystectomy.
Settings and Design: Double-blind, randomized, placebo-controlled
study. Materials and Methods: Two hundred and fifty patients of ASA
physical status I and II, scheduled for laparoscopic cholecystectomy
were randomly assigned into two equal groups to receive 600 mg
gabapentin or matching placebo two hours before surgery. Standard
anaesthesia technique was used. Fentanyl was used as rescue
postoperative analgesic. Ondansetron 4 mg was used intravenously as
rescue medication for emesis. The total number of patients who had
nausea or vomiting, and its severity and total fentanyl consumption in
the first 24 hours were recorded. Statistical Analysis: "Z test" was
used to test the significance of severity of post-operative nausea and
vomiting between groups. Fentanyl consumed in each group (Mean±SD)
within 24 hrs was compared using student t test. P value< 0.05 was
considered significant. Results: There were no demographic difference
between the two groups. Incidence of post-operative nausea and vomiting
within 24 hrs after laparoscopic cholecystectomy was significantly
lower in gabapentin group (46/125) than in the placebo group (75/125)
(37.8% vs 60%; P =0.04). There was a significantly decreased fentanyl
consumption in gabapentin group (221.2±92.4 µg) as compared
to placebo group (505.9±82.0 µg; P =0.01). Conclusion:
Gabapentin effectively suppresses nausea and vomiting in laparoscopic
cholecystectomy and post-operative rescue analgesic requirement